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From the Editor-in-Chief
n association between low bone mineral density and all-cause
mortality, especially due to stroke, has been described in elderly
women. Furthermore, aortic calcification may be more common
among women with osteoporotic vertebral fractures, and the degree of
aortic calcification is inversely related to bone mineral density. Osteoporo-
sis and cardiovascular disease thus seem to be associated.
Here we collected papers focused on this relationship from different an-
gles. Two reports, one from P. Piscitelli and the other from G.N. Farhat,
highlight the epidemiologic literature on the association of cardiovascular
phenotypes and osteoporosis, also summarizing the potential mechani-
sms involved in the link between low bone mineral density and cardiova-
scular disease.
Molecular biology of bone remodelling and of atherosclerosis are descri-
bed in two reports, respectively by N. Rucci and E. Mannarino. New di-
scoveries about genetic triggers may help us spot trouble before it starts,
as elegantly described in the article by R. Abbate.
It has been known for many years that calcification of large arteries is com-
mon among patients with endstage renal disease. A critical analysis of the
cause factors that underlie this association is reviewed by K.A. Hruska.
The innovative instrumental diagnostic tools to evaluate the co-segrega-
tion of low bone mineral density and arterial calcification summarized by
C. Cepollaro mark the future approaches in the evaluation of the single
patient as potentially at risk for fragility fractures and/or for cardiovascular
disorders.
Finally, C.E. Fiore analyzed the role of old and new drugs in facing bone
loss and atherosclerosis. We are confident that an informed approach to
the treatment of elderly patients will help in the future to offer clear con-
cepts to readers often left confused. This critical analysis will lessen the apparent divergence of views
and point the way to a possible synthesis. Testable hypotheses are presented whose evaluation may help
clarify this vital field of study.
We think aggressive control of vascular risk factors in addition to the known existing osteoporosis risk fac-
tors may help to reduce the morbidity and mortality associated with these diseases. The cross-fertilization
of two exploding areas of basic and clinical research will contribute to form and inform the future genera-
tions of physicians.
Maria Luisa Brandi, M.D., Ph.D.
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